Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid.
K Kikugawa, T Kojima, S Yamaki...
https://pubmed.ncbi.nlm.nih.gov/1519749/Actively Recruiting
Led by University of La Laguna · Updated on 2026-08-12
200
Participants Needed
1
Research Sites
17 weeks
Total Duration
This research investigates the role of oxidative stress in patients with rheumatoid arthritis RA, a chronic inflammatory autoimmune disease that affects about 1% of the population and is linked to accelerated atherosclerosis. The study aims to evaluate the association between oxidative stress markersserum malondialdehyde MDA, superoxide dismutase SOD, and glutathione peroxidase GPXand subclinical atherosclerosis and carotid arterial stiffness in RA patients. It also explores how these markers relate to cardiovascular risk factors such as inflammatory dyslipidemia, insulin resistance, and beta-cell dysfunction. Participants with RA will undergo measurements of serum MDA levels and plasma SOD and GPX activity as indicators of oxidative stress. The study is a 24-month cross-sectional observational design, with recruitment planned from January 2024 through May 2025. Patients will be assessed for carotid intima-media thickness, carotid plaque, and carotid stiffness, alongside detailed lipid profiles and insulin resistance indices. Data collection includes blood samples, clinical assessments, and questionnaires related to disease activity and treatment. During the study, participants will have a baseline visit where blood samples and clinical data are collected. Researchers will analyze oxidative stress markers, lipid profiles, and cardiovascular indicators, adjusting for factors like age, sex, body mass index, and medication use. The primary outcomes include serum levels of SOD and oxidative stress measurements over the study period. The study will conclude with data analysis and report submission by the end of 2026, providing insights into the link between oxidative stress and cardiovascular disease in RA.
CONDITIONS
Oxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis
I
Ivan Ferraz, MD
E
Elsa Oramas
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of La Laguna
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - One-time visit
Participants undergo blood sample collection, ultrasound scans of carotid arteries, and complete questionnaires about rheumatoid arthritis disease activity and treatments.
1 visit (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
K Kikugawa, T Kojima, S Yamaki...
https://pubmed.ncbi.nlm.nih.gov/1519749/Marco Landi
https://pubmed.ncbi.nlm.nih.gov/28456836/A Valenzuela
https://pubmed.ncbi.nlm.nih.gov/1990230/University of La Laguna
Lead Sponsor